We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Hyperacute synchronous cardiocerebral infarction in a patient with new-onset atrial fibrillation: a case of myocardial infarction with nonobstructive coronary arteries

    Panteleimon E Papakonstantinou

    *Author for correspondence: Tel.: +30 213 204 1466;

    E-mail Address: pantelispapakon@gmail.com

    Second Cardiology Department, Evangelismos Hospital, Athens, 10676, Greece

    ,
    Malamati-Eleni Lentza

    Neurology Department, Evangelismos Hospital, Athens, 10676, Greece

    ,
    Konstantinos Manousiadis

    Second Cardiology Department, Evangelismos Hospital, Athens, 10676, Greece

    ,
    Ilianna Bei

    Second Cardiology Department, Evangelismos Hospital, Athens, 10676, Greece

    ,
    Maria Panourgia

    Neurology Department, Evangelismos Hospital, Athens, 10676, Greece

    ,
    Dimitra Tachmetzidi-Papoutsi

    Radiology Department, Evangelismos Hospital, Athens, 10676, Greece

    ,
    Sotirios Xydonas

    Second Cardiology Department, Evangelismos Hospital, Athens, 10676, Greece

    &
    Antonios Sideris

    Second Cardiology Department, Evangelismos Hospital, Athens, 10676, Greece

    Published Online:https://doi.org/10.2217/fca-2022-0136

    Hyperacute synchronous cardiocerebral infarction (CCI) is an extremely rare condition with an incidence of 0.009%. In the acute stage of ischemic stroke, there is a high prevalence of ECG abnormalities. Prolonged QTc, atrial fibrillation (AF) and ECG changes indicative of ischemic heart disease, such as Q waves, ST depression, and T wave inversion, were the most prevalent changes. There are three types of simultaneous CCI: cardiac conditions that cause cerebral infarction, cerebral infarction caused by cardiac conditions, and (c) dysregulation of the brain–heart axis or cerebral infarction causing myocardial infarction. Herein, we present a case of hyperacute synchronous CCI in an elderly patient with new-onset AF and myocardial infarction with nonobstructive coronary arteries (MINOCA).

    References

    • 1. Yeo LLL, Andersson T, Yee KW et al. Synchronous cardiocerebral infarction in the era of endovascular therapy: which to treat first? J. Thromb. Thrombolysis 44(1), 104–111 (2017).
    • 2. Omar HR, Fathy A, Rashad R, Helal E. Concomitant acute right ventricular infarction and ischemic cerebrovascular stroke; possible explanations. Int. Arch. Med. 3, 25 (2010).
    • 3. Ng TP, Wong C, Leong ELE et al. Simultaneous cardio-cerebral infarction: a meta-analysis. QJM: Mon. J. Assoc. Physicians 115(6), 374–380 (2022).
    • 4. Kijpaisalratana N, Chutinet A, Suwanwela NC. Hyperacute simultaneous cardiocerebral infarction: rescuing the brain or the heart first? Front. Neurol. 8, 664 (2017).
    • 5. Fure B, Bruun Wyller T, Thommessen B. Electrocardiographic and troponin T changes in acute ischaemic stroke. J. Intern. Med. 259(6), 592–597 (2006).
    • 6. Tahsili-Fahadan P, Geocadin RG. Heart-brain axis: effects of neurologic injury on cardiovascular function. Circ. Res. 120(3), 559–572 (2017).
    • 7. Collet JP, Thiele H, Barbato E et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 42(14), 1289–1367 (2021).
    • 8. Pathik B, Raman B, Mohd Amin NH et al. Troponin-positive chest pain with unobstructed coronary arteries: incremental diagnostic value of cardiovascular magnetic resonance imaging. Eur. Heart J. Cardiovasc. Imaging 17(10), 1146–1152 (2016).
    • 9. Redfors B, Råmunddal T, Shao Y, Omerovic E. Takotsubo triggered by acute myocardial infarction: a common but overlooked syndrome? J. Geriatr. Cardiol. 11(2), 171–173 (2014).
    • 10. Powers WJ, Rabinstein AA, Ackerson T et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 50(12), e344–e418 (2019).
    • 11. Ibanez B, James S, Agewall S et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 39(2), 119–177 (2018).
    • 12. Berge E, Whiteley W, Audebert H, De Marchis GM, Fonseca AC. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. 6(1), I–LXII (2021).
    • 13. Bálint A, Tornyos D, El Alaoui El Abdallaoui O, Kupó P, Komócsi A. Network meta-analysis of ticagrelor for stroke prevention in patients at high risk for cardiovascular or cerebrovascular events. Stroke 52(9), 2809–2816 (2021).
    • 14. Tornyos D, Komócsi A, Bálint A et al. Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: a multiple treatment network meta-analysis of randomized controlled trials. PLOS ONE 17(8), e0273103 (2022).
    • 15. Szapáry L, Tornyos D, Kupó P, Lukács R, El Alaoui El Abdallaoui O, Komócsi A. Combination of antiplatelet and anticoagulant therapy, component network meta-analysis of randomized controlled trials. Front. Cardiovasc. Med. 9, 1036609 (2022).
    • 16. Elnour AA, Komócsi A, Kupó P et al. The role of direct oral anticoagulant in patients with acute coronary syndrome on single or dual antiplatelet regime: review of opportunities and challenges. Curr. Rev. Clin. Exp. Pharmacol. 16(1), 52–63 (2021).